A review of retrospective data sought to better understand the relationship between obesity and survival in renal cell carcinoma.
Local surgery or ablation may be most appropriate for patients with a solitary site of locoregional recurrence following definitive surgery for clinically localized renal cell carcinoma, according to investigators.
Researchers determined the most common sites of metastasis and their association with overall survival rate for the 3 main subtypes of RCC.
A study was conducted to assess factors contributing to response to nivolumab treatment for advanced clear cell renal cell carcinoma.
Belzutifan is a potent and selective inhibitor of HIF-2α.